STAT5B and thoracolaryngopelvic dysplasia: Recent studies revealed recurrent activating mutations of STAT5B (18) and loss-of-function mutations of SETD2 (19) in MEITL cases, which can be useful for distinguishing MEITL cases from indolent GI T-LPD cases.